 |
 Video: What is a Stock Split?
|
|
|
| Cellect Biotechnology is a global biotechnology group based in Israel. Co. is engaged in the production of regenerative medicine through the development of products facilitating immune stem cell selection. Co.'s platform technology is based on the functional properties of stem cells which are used for their identification, selection and utilization. Co.'s first product is designed to harness the critical function of sensitivity to specific apoptosis-inducing agents. Co. has established a proof of concept for its technology in animals, and has built a comprehensive IP portfolio protecting its development. Co. is involved in clinical trials and is working on the development of its pipeline. According to our APOPW stock split history records, APOPW has had 0 splits. | |
|
APOPW (APOPW) has 0 splits in our APOPW stock split history database.
Looking at the APOPW stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into APOPW shares, starting with a $10,000 purchase of APOPW, presented on a split-history-adjusted basis factoring in the complete APOPW stock split history.
APOPW -- use the split history when considering split-adjusted past price performance. |
|
|
|
